Arcus Biosciences RCUS Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's operating lease liabilities (current)?
- Arcus Biosciences (RCUS) reported operating lease liabilities (current) of $13M in Q1 2026.
- How has Arcus Biosciences's operating lease liabilities (current) changed year-over-year?
- Arcus Biosciences's operating lease liabilities (current) increased by 8.3% year-over-year, from $12M to $13M.
- What is the long-term trend for Arcus Biosciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Arcus Biosciences's operating lease liabilities (current) has grown at a 35.3% compound annual growth rate (CAGR), from $2.87M to $13M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.